The Healthcare Distribution Management Association (HDMA) presented its first Distribution Management Award to AmerisourceBergen Packaging Group (ABPG) and Pfizer Pharmaceuticals for its Toviaz™ Physician Sample Package Optimization project. The award, presented at the association’s 2010 Distribution Management Conference & Technology Expo in Baltimore, recognizes member companies’ efforts to improve the efficiency and effectiveness of the healthcare supply chain and enhance trading partner relationships.
Pfizer’s Toviaz, a treatment for overactive bladders, was introduced to the market in 2008 using a child-resistant starter pack for physician samples. In partnership with ABPG company Anderson Packaging, the companies worked together to improve upon this design by transitioning to a more comprehensive package design, using ABPG’s IntuiDose™ child-resistant compliance-prompting format. This enhanced design helped Pfizer to deliver the medication more effectively and cost-efficiently. The improvements resulted in savings in the Toviaz physician sample program and a more patient-friendly product. The new packaging helped to lower processing and operation costs and led to more efficient transportation and distribution.
The Distribution Management Award is the successor to HDMA’s iBusiness Solution and Innovation for Success Awards. HDMA presents the award to a member company or companies that demonstrate the value of distribution by developing creative, results-oriented programs and processes in areas ranging from technology and operations to trade and promotional planning that benefit the healthcare supply chain, customers and consumers, and engage in successful trading partner relationships.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.